Please visit the MODEL-AD booth (#14)
MODEL-AD presentations
TALKS
Tuesday March 5
PRE CONFERENCE SYMPOSIUM 01: CREATING MEANING OUT OF CHAOS: LINKING BIG DATA TOOLS TO PATHOPHYSIOLOGY, BIOMARKERS, DIAGNOSES AND CLINICAL STUDIES
MULTI-OMIC APPROACHES TO UNCOVER DISEASE MODELS FOR NEURODEGENERATIVE DISEASES OF THE EYE AND BRAIN
Gareth Howell, The Jackson Lab
Lecture Time
13:15 – 13:35
Wednesday March 6
TRANSLATIONAL DRUG DISCOVERY AND EXPERIMENTAL MODELS 01
Session Time: 14:30 – 16:30
Room: Auditorium V
MODELING LATE-ONSET ALZHEIMER’S DISEASE IN MICE
Frank Laferla, UCI
Lecture Time: 14:45-15:00
SEX DIFFERENCES IN MOUSE MODELS OF ALZHEIMER’S DISEASE
Asli Uyar, The Jackson Lab
Lecture Time: 15:00 – 15:15
Thursday March 7
GENETICS, EPIDEMIOLOGY
Session Time: 8:40 – 10:40
Room: Auditorium II
TRANSCRIPTIONAL ANALYSIS OF MOUSE MODELS HARBORING CODING AND NONCODING HUMAN GENETIC VARIANTS FOR LATE-ONSET ALZHEIMER’S DISEASE
Greg Carter, The Jackson Lab
Lecture Time: 9:10 – 09:25
POSTERS
P0634 / #504
AN INTEGRATIVE MULTI-OMICS APPROACH REVEALS MOLECULAR SIGNATURES ASSOCIATED WITH DISTINCT AD RISK FACTORS IN MOUSE MODELS OF ALZHEIMER’S DISEASE
Pandey et al
P0617 / #777
NOVEL KLOTHO MOUSE MODELS TO EXAMINE PROTECTION AGAINST APOE4 RISK FOR ALZHEIMER’S DISEASE
Sasner et al
P0271 / #836
NICOTINIC ACID RECEPTOR HCAR2 AFFECTS MICROGLIA RESPONSE AND AMYLOID PATHOLOGY AT EARLY- AND LATE-STAGE DISEASE
Moutinho et al
P0208 / #863
BRAIN METABOLIC CONNECTOMICS OF ADUCANUMAB PHARMACODYNAMICS IN 5XFAD MICE
Territo et al
P0394/#1104
CEREBRAL PERFUSION AND METABOLISM ACROSS THE LIFESPAN OF THE NOVEL HUMAN AMYLOID BETA KNOCK-IN MOUSE MODEL OF ALZHEIMER’S DISEASE.
Obenaus et al
P0072 / #1148
RELATIONSHIPS BETWEEN SIGNAL TRANSDUCTION DISRUPTIONS CAUSED BY MAP KINASES IN ALZHEIMER’S DISEASE
Keegan et al
P0117 / #1197
TOTAL PLCG2 DEPLETION IMPAIRS MICROGLIAL RESPONSES AND CONFERS DIVERSE TRANSCRIPTIONAL ALTERATIONS IN A MURINE MODEL OF ALZHEIMER’S DISEASE
Messenger et al
P0765 / #1311
THERAPEUTIC POTENTIAL OF NICOTINIC ACID IN PS19 TAUOPATHY MICE.
Coronel et al
P0628 / #1421
INVESTIGATING ABCA7-MEDIATED PHENOTYPES IN A HUMANIZED, LATE-ONSET ALZHEIMER’S DISEASE MOUSE MODEL
Kotredes et al
P0642 / #1817
BIOLOGICAL DOMAIN AND SUBDOMAIN MAPPING OF AD ENRICHED BIOLOGICAL PROCESSES
Wiley et al
P0674 / #1844
GENOMIC ANALYSIS OF FIBROBLASTS FROM MARMOSETS CARRYING EARLY-ONSET ALZHEIMER’S DISEASE MUTATIONS IN PSEN1
Carter et al
P0629 / #1873
CONTRIBUTIONS OF MTHFR RISK ALLELE TO DISEASE PROGRESSION IN LATE-ONSET ALZHEIMER’S DISEASE
Kotredes et al
P0574 / #1886
CONSEQUENCES OF NEUROTOXIANT EXPOSURE IN MOUSE MODELS OF LATE-ONSET ALZHEIMER’S DISEASE
Kotredes et al
P0625 / #1903
PSEUDO-TEMPORAL MODELS OF ALZHEIMER’S DISEASE ACROSS BRAIN-DERIVED TRANSCRIPTOMICS AND PROTEOMICS REVEAL UNIQUE INSIGHTS INTO EARLY MOLECULAR CHANGES LEADING TO DISEASE
Heath et al
P0607 / #1986
DETERMINING HOW COMPLEX INTERACTIONS BETWEEN APOE ALLELIC SERIES AND GENETIC BACKGROUND CONTRIBUTE EARLY TO ALZHEIMER’S DISEASE RISK
Onos et al
P0669 / #2329
INTEGRATING GENOMIC AND ENVIRONMENTAL FACTORS FOR THE DEVELOPMENT OF PRECLINICAL MODELS OF LATE-ONSET ALZHEIMER’S DISEASE
Oblak et al
P0073/#2846
PHENOTYPIC CHARACTERIZATION OF A NOVEL SPI1*RS1377416 MOUSE MODEL OF ALZHEIMER’S DISEASE.
Milinkeviciute et al